126 related articles for article (PubMed ID: 38918700)
1. Computer-vision analysis of craniofacial dysmorphology in 22q11.2 deletion syndrome and psychosis spectrum disorders.
Roalf DR; McDonald-McGinn DM; Jee J; Krall M; Crowley TB; Moberg PJ; Kohler C; Calkins ME; Crow AJD; Fleischer N; Gallagher RS; Gonzenbach V; Clark K; Gur RC; McClellan E; McGinn DE; Mordy A; Ruparel K; Turetsky BI; Shinohara RT; White L; Zackai E; Gur RE
J Neurodev Disord; 2024 Jun; 16(1):35. PubMed ID: 38918700
[TBL] [Abstract][Full Text] [Related]
2. Early language measures associated with later psychosis features in 22q11.2 deletion syndrome.
Solot CB; Moore TM; Crowley TB; Gerdes M; Moss E; McGinn DE; Emanuel BS; Zackai EH; Gallagher S; Calkins ME; Ruparel K; Gur RC; McDonald-McGinn DM; Gur RE
Am J Med Genet B Neuropsychiatr Genet; 2020 Sep; 183(6):392-400. PubMed ID: 32715620
[TBL] [Abstract][Full Text] [Related]
3. Craniofacial dysmorphology in 22q11.2 deletion syndrome by 3D laser surface imaging and geometric morphometrics: illuminating the developmental relationship to risk for psychosis.
Prasad S; Katina S; Hennessy RJ; Murphy KC; Bowman AW; Waddington JL
Am J Med Genet A; 2015 Mar; 167A(3):529-36. PubMed ID: 25691406
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome.
Weinberger R; Yi J; Calkins M; Guri Y; McDonald-McGinn DM; Emanuel BS; Zackai EH; Ruparel K; Carmel M; Michaelovsky E; Weizman A; Gur RC; Gur RE; Gothelf D
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1610-8. PubMed ID: 27524298
[TBL] [Abstract][Full Text] [Related]
5. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal perspectives on the psychosis spectrum in 22q11.2 deletion syndrome.
Tang SX; Gur RE
Am J Med Genet A; 2018 Oct; 176(10):2192-2202. PubMed ID: 29048724
[TBL] [Abstract][Full Text] [Related]
7. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.
Sun D; Ching CRK; Lin A; Forsyth JK; Kushan L; Vajdi A; Jalbrzikowski M; Hansen L; Villalon-Reina JE; Qu X; Jonas RK; van Amelsvoort T; Bakker G; Kates WR; Antshel KM; Fremont W; Campbell LE; McCabe KL; Daly E; Gudbrandsen M; Murphy CM; Murphy D; Craig M; Vorstman J; Fiksinski A; Koops S; Ruparel K; Roalf DR; Gur RE; Schmitt JE; Simon TJ; Goodrich-Hunsaker NJ; Durdle CA; Bassett AS; Chow EWC; Butcher NJ; Vila-Rodriguez F; Doherty J; Cunningham A; van den Bree MBM; Linden DEJ; Moss H; Owen MJ; Murphy KC; McDonald-McGinn DM; Emanuel B; van Erp TGM; Turner JA; Thompson PM; Bearden CE
Mol Psychiatry; 2020 Aug; 25(8):1822-1834. PubMed ID: 29895892
[TBL] [Abstract][Full Text] [Related]
8. Predicting Cognition and Psychosis in Young Adults With 22q11.2 Deletion Syndrome.
Antshel KM; Fremont W; Ramanathan S; Kates WR
Schizophr Bull; 2017 Jul; 43(4):833-842. PubMed ID: 27798222
[TBL] [Abstract][Full Text] [Related]
9. Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.
Yi JJ; Tang SX; McDonald-McGinn DM; Calkins ME; Whinna DA; Souders MC; Zackai EH; Goldmuntz E; Gaynor JW; Gur RC; Emanuel BS; Gur RE
Am J Med Genet B Neuropsychiatr Genet; 2014 Mar; 165B(2):137-47. PubMed ID: 24265253
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal study of premorbid adjustment in 22q11.2 deletion (velocardiofacial) syndrome and association with psychosis.
Radoeva PD; Fremont W; Antshel KM; Kates WR
Dev Psychopathol; 2017 Feb; 29(1):93-106. PubMed ID: 26864886
[TBL] [Abstract][Full Text] [Related]
11. Ranbp1 modulates morphogenesis of the craniofacial midline in mouse models of 22q11.2 deletion syndrome.
Paronett EM; Bryan CA; Maynard ME; Goroff JA; Meechan DW; LaMantia AS; Maynard TM
Hum Mol Genet; 2023 Jun; 32(12):1959-1974. PubMed ID: 36790128
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome Profiling of Peripheral Blood in 22q11.2 Deletion Syndrome Reveals Functional Pathways Related to Psychosis and Autism Spectrum Disorder.
Jalbrzikowski M; Lazaro MT; Gao F; Huang A; Chow C; Geschwind DH; Coppola G; Bearden CE
PLoS One; 2015; 10(7):e0132542. PubMed ID: 26201030
[TBL] [Abstract][Full Text] [Related]
13. Altered cortical thickness development in 22q11.2 deletion syndrome and association with psychotic symptoms.
Bagautdinova J; Zöller D; Schaer M; Padula MC; Mancini V; Schneider M; Eliez S
Mol Psychiatry; 2021 Dec; 26(12):7671-7678. PubMed ID: 34253864
[TBL] [Abstract][Full Text] [Related]
14. Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness.
Ching CRK; Gutman BA; Sun D; Villalon Reina J; Ragothaman A; Isaev D; Zavaliangos-Petropulu A; Lin A; Jonas RK; Kushan L; Pacheco-Hansen L; Vajdi A; Forsyth JK; Jalbrzikowski M; Bakker G; van Amelsvoort T; Antshel KM; Fremont W; Kates WR; Campbell LE; McCabe KL; Craig MC; Daly E; Gudbrandsen M; Murphy CM; Murphy DG; Murphy KC; Fiksinski A; Koops S; Vorstman J; Crowley TB; Emanuel BS; Gur RE; McDonald-McGinn DM; Roalf DR; Ruparel K; Schmitt JE; Zackai EH; Durdle CA; Goodrich-Hunsaker NJ; Simon TJ; Bassett AS; Butcher NJ; Chow EWC; Vila-Rodriguez F; Cunningham A; Doherty J; Linden DE; Moss H; Owen MJ; van den Bree M; Crossley NA; Repetto GM; Thompson PM; Bearden CE
Am J Psychiatry; 2020 Jul; 177(7):589-600. PubMed ID: 32046535
[TBL] [Abstract][Full Text] [Related]
15. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
[TBL] [Abstract][Full Text] [Related]
16. Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis.
Goldenberg PC; Calkins ME; Richard J; McDonald-McGinn D; Zackai E; Mitra N; Emanuel B; Devoto M; Borgmann-Winter K; Kohler C; Conroy CG; Gur RC; Gur RE
Am J Med Genet B Neuropsychiatr Genet; 2012 Jan; 159B(1):87-93. PubMed ID: 22170773
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of substance use in people with 22q11.2 deletion syndrome.
Vingerhoets C; van Oudenaren MJF; Bloemen OJN; Boot E; van Duin EDA; Evers LJM; Fiksinski AM; Breetvelt EJ; Palmer LD; Vergaelen E; Vogels A; Meijer C; Booij J; ; de Haan L; Swillen A; Vorstman JAS; Bassett AS; van Amelsvoort TAMJ
Br J Psychiatry; 2019 Nov; 215(5):661-667. PubMed ID: 30604657
[TBL] [Abstract][Full Text] [Related]
18. Large-Scale Brain Network Dynamics Provide a Measure of Psychosis and Anxiety in 22q11.2 Deletion Syndrome.
Zöller D; Sandini C; Karahanoğlu FI; Padula MC; Schaer M; Eliez S; Van De Ville D
Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Oct; 4(10):881-892. PubMed ID: 31171499
[TBL] [Abstract][Full Text] [Related]
19. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.
Vorstman JA; Breetvelt EJ; Duijff SN; Eliez S; Schneider M; Jalbrzikowski M; Armando M; Vicari S; Shashi V; Hooper SR; Chow EW; Fung WL; Butcher NJ; Young DA; McDonald-McGinn DM; Vogels A; van Amelsvoort T; Gothelf D; Weinberger R; Weizman A; Klaassen PW; Koops S; Kates WR; Antshel KM; Simon TJ; Ousley OY; Swillen A; Gur RE; Bearden CE; Kahn RS; Bassett AS;
JAMA Psychiatry; 2015 Apr; 72(4):377-85. PubMed ID: 25715178
[TBL] [Abstract][Full Text] [Related]
20. Favorable effects of omega-3 polyunsaturated fatty acids in attentional control and conversion rate to psychosis in 22q11.2 deletion syndrome.
Armando M; Ciampoli M; Padula MC; Amminger P; De Crescenzo F; Maeder J; Schneider M; Schaer M; Managò F; Eliez S; Papaleo F
Neuropharmacology; 2020 May; 168():107995. PubMed ID: 32057798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
